selected publications
-
A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 24 -
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2020
Academic Article
GET IT
Times cited: 43 -
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.
Journal of gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 31 -
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 84 -
Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old.
Annals of surgical oncology.
2018
Academic Article
GET IT
Times cited: 25 -
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer.
Gynecologic oncology.
2018
Academic Article
GET IT
Times cited: 19 -
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Gynecologic oncology.
2017
Academic Article
GET IT
Times cited: 48 -
Abdominal wall endometriosis: differentiation from other masses using CT features.
Abdominal radiology (New York).
2017
Academic Article
GET IT
Times cited: 27 -
Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.
2017
GET IT
Times cited: 21 -
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 14 - Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. 2016 GET IT
-
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 3 -
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.
Gynecologic oncology.
2016
Academic Article
GET IT
Times cited: 110 -
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2016
Academic Article
GET IT
Times cited: 22 -
Development of a risk stratification system to guide treatment for female germ cell tumors.
Gynecologic oncology.
2015
Academic Article
GET IT
Times cited: 38 -
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 201 -
The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications.
Gynecologic oncology.
2014
Academic Article
GET IT
Times cited: 49 -
Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy.
Gynecologic oncology.
2013
Academic Article
GET IT
Times cited: 27 -
Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
2013
Academic Article
GET IT
Times cited: 15 -
Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Gynecologic oncology.
2012
Academic Article
GET IT
Times cited: 50 -
Covered esophageal self-expandable metal stents in the nonoperative management of postoperative colorectal anastomotic leaks.
Gastrointestinal endoscopy.
2012
Academic Article
GET IT
Times cited: 16 -
Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.
Gynecologic oncology.
2011
Academic Article
GET IT
Times cited: 54 -
Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.
Gynecologic oncology.
2011
Editorial Article
GET IT
Times cited: 92 -
CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: a gynecologic oncology group study.
Gynecologic oncology.
2011
Academic Article
GET IT
Times cited: 6 -
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.
Gynecologic oncology.
2011
Academic Article
GET IT
Times cited: 46 -
Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document.
Gynecologic oncology.
2011
Review
GET IT
Times cited: 254 -
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma.
Gynecologic oncology.
2011
Academic Article
GET IT
Times cited: 35 -
Current and future directions of clinical trials for ovarian cancer.
Cancer control : journal of the Moffitt Cancer Center.
2011
Review
GET IT
Times cited: 18 -
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.
Gynecologic oncology.
2010
Academic Article
GET IT
Times cited: 12 -
Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2010
Academic Article
GET IT
Times cited: 31 -
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.
Gynecologic oncology.
2009
Academic Article
GET IT
Times cited: 23 -
Ovarian cancer cytoreductive surgery in the elderly.
Current treatment options in oncology.
2009
Review
GET IT
Times cited: 7 -
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2007
Academic Article
GET IT
Times cited: 102 -
Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
Cancer.
2007
Academic Article
GET IT
Times cited: 73 -
The role of cytoreductive surgery for colon cancer metastatic to the ovary.
Gynecologic oncology.
2007
Academic Article
GET IT
Times cited: 48 -
Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Cancer.
2007
Academic Article
GET IT
Times cited: 144 -
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2007
Academic Article
GET IT
Times cited: 62 -
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Gynecologic oncology.
2006
Academic Article
GET IT
Times cited: 59 -
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis.
Gynecologic oncology.
2006
Academic Article
GET IT
Times cited: 31 -
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
Oncogene.
2006
Academic Article
GET IT
Times cited: 102 -
Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.
Gynecologic oncology.
2006
Academic Article
GET IT
Times cited: 47 -
Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality.
Gynecologic oncology.
2006
Academic Article
GET IT
Times cited: 33 -
Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Gynecologic oncology.
2006
Academic Article
GET IT
Times cited: 62 -
Salvage cytoreductive surgery for recurrent endometrial cancer.
Gynecologic oncology.
2006
Academic Article
GET IT
Times cited: 63 -
Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2005
Academic Article
GET IT
Times cited: 137 -
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Cancer research.
2005
Academic Article
GET IT
Times cited: 273 -
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2005
Academic Article
GET IT
Times cited: 337 -
Surgical care of elderly women with ovarian cancer: a population-based perspective.
Gynecologic oncology.
2005
Academic Article
GET IT
Times cited: 58 -
Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: analysis of first 100 cases.
Gynecologic oncology.
2005
Academic Article
GET IT
Times cited: 35 -
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines.
Cell death and differentiation.
2004
Academic Article
GET IT
Times cited: 37 -
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Gynecologic oncology.
2004
Academic Article
GET IT
Times cited: 33 -
Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Journal of medicinal chemistry.
2004
Academic Article
GET IT
Times cited: 67 -
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2003
Academic Article
GET IT
Times cited: 88 -
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
Oncogene.
2002
Academic Article
GET IT
Times cited: 54 -
Ovarian tumors of low malignant potential: Can molecular biology solve this enigma?.
Journal of the National Cancer Institute.
2001
Editorial Article
GET IT
Times cited: 5 -
Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures.
The Journal of neuroscience : the official journal of the Society for Neuroscience.
2000
Academic Article
GET IT
Times cited: 53 -
The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury.
Neuroscience.
1994
Academic Article
GET IT
Times cited: 70